232 related articles for article (PubMed ID: 19695936)
1. [Prostate cancer: what role for curative radiotherapy in elderly?].
Nguyen TD; Azria D; Brochon D; Poortmans P; Miller RC
Cancer Radiother; 2009 Oct; 13(6-7):623-7. PubMed ID: 19695936
[TBL] [Abstract][Full Text] [Related]
2. Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: a retrospective rare cancer network study.
Nguyen TD; Azria D; Brochon D; Poortmans P; Miller RC; Scandolaro L; Majewski W; Krengli M; Abacioglu U; Moretti L; Villa S; Akyol F; Jovenin N
Crit Rev Oncol Hematol; 2010 Apr; 74(1):66-71. PubMed ID: 19419885
[TBL] [Abstract][Full Text] [Related]
3. [Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network].
Nguyen TD; Poortmans PM; van der Hulst M; Studer G; Pigois E; Collen TD; Belkacemi Y; Beckendorf V; Miralbell R; Scandolaro L; Soete G; Villa S; Gez E; Thomas O; Krengli M; Saliou M;
Bull Cancer; 2004 Dec; 91(12):959-64. PubMed ID: 15634636
[TBL] [Abstract][Full Text] [Related]
4. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
[TBL] [Abstract][Full Text] [Related]
5. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.
Ogawa K; Nakamura K; Sasaki T; Onishi H; Koizumi M; Shioyama Y; Araya M; Mukumoto N; Mitsumori M; Teshima T;
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):759-65. PubMed ID: 19327908
[TBL] [Abstract][Full Text] [Related]
6. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
7. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality.
Zelefsky MJ; Shi W; Yamada Y; Kollmeier MA; Cox B; Park J; Seshan VE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1350-6. PubMed ID: 19515504
[TBL] [Abstract][Full Text] [Related]
8. Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy.
Pantarotto J; Malone S; Dahrouge S; Gallant V; Eapen L
BJU Int; 2007 Mar; 99(3):564-9. PubMed ID: 17166241
[TBL] [Abstract][Full Text] [Related]
9. Single-institution results of primary external-beam radiation for the treatment of t1-t3 prostate cancer.
Weiss W; Horninger W; Forthuber BC; Ulmer H; Lukas P; Sweeney RA
Strahlenther Onkol; 2007 Jun; 183(6):321-6. PubMed ID: 17520186
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer.
Zelefsky MJ; Yamada Y; Kollmeier MA; Shippy AM; Nedelka MA
Eur Urol; 2008 Jun; 53(6):1172-9. PubMed ID: 18222596
[TBL] [Abstract][Full Text] [Related]
11. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
[TBL] [Abstract][Full Text] [Related]
12. Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
Aizer AA; Yu JB; McKeon AM; Decker RH; Colberg JW; Peschel RE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1344-9. PubMed ID: 19464821
[TBL] [Abstract][Full Text] [Related]
13. Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men.
van den Bergh RC; Roemeling S; Roobol MJ; Aus G; Hugosson J; Rannikko AS; Tammela TL; Bangma CH; Schröder FH
BJU Int; 2009 Jun; 103(11):1472-7. PubMed ID: 19154509
[TBL] [Abstract][Full Text] [Related]
14. External-beam radiotherapy for localized or locally advanced prostate cancer in Japan: a multi-institutional outcome analysis.
Nakamura K; Mizowaki T; Imada H; Karasawa K; Uno T; Onishi H; Nihei K; Sasaki S; Ogura M; Akimoto T
Jpn J Clin Oncol; 2008 Mar; 38(3):200-4. PubMed ID: 18304950
[TBL] [Abstract][Full Text] [Related]
15. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
[TBL] [Abstract][Full Text] [Related]
16. Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome.
Ricciardelli C; Sakko AJ; Stahl J; Tilley WD; Marshall VR; Horsfall DJ
Prostate; 2009 May; 69(7):761-9. PubMed ID: 19189303
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of radiotherapy for prostate cancer.
Swanson GP; Riggs MW; Earle JD
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):406-11. PubMed ID: 15145156
[TBL] [Abstract][Full Text] [Related]
18. Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.
Choo R; Danjoux C; Gardner S; Morton G; Szumacher E; Loblaw DA; Cheung P; Pearse M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):407-12. PubMed ID: 19211197
[TBL] [Abstract][Full Text] [Related]
19. Prostate brachytherapy in men > or =75 years of age.
Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Adamovich E
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):415-20. PubMed ID: 18374514
[TBL] [Abstract][Full Text] [Related]
20. The role of radiation therapy in the treatment of cancer of the prostate.
Korzeniowski S
Neoplasma; 1988; 35(4):443-57. PubMed ID: 3054590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]